The MS Co-O perative Research (MS-CORE) group: an alternate approach to fostering multicenter studies

Abstract

Get full access to this article

View all access options for this article.

References

Kappos L , Polman C , Thompson AJ , Duda P , Clanet M , Hartung HP et al. Towards a European Network for Multiple Sclerosis Trials (ENMST) . Mult Scler 2003; 9: 627-629 .

McDonald WI , Compston A , Edan G , Goodkin D , Hartung HP , Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis . Ann Neurol 2001; 50: 121-127 .

Lublin FD , Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis . Neurology 1996; 46: 907-911 .

Lublin FD , Reingold SC. Combination therapy for treatment of multiple sclerosis . Ann Neurol 1998; 44: 7-9 .

Lublin FD , Reingold SC. Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: relations between study investigators, advisors, and sponsors. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis . Neurology 1997; 48: 572-574 .

Lublin FD , Reingold SC. Placebo-controlled clinical trials in multiple sclerosis: ethical considerations. National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MS . Ann Neurol 2001; 49: 677-681 .

Whitaker JN , McFarland HF , Rudge P , Reingold SC. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis . Mult Scler 1995; 1: 37-47 .

Rudick R , Antel J , Confavreux C , Cutter G , Ellison G , Fischer J et al. Clinical outcomes assessment in multiple sclerosis . Ann Neurol 1996; 40: 469-479 .

Rudick R , Antel J , Confavreux C , Cutter G , Ellison G , Fischer J et al. Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force . Ann Neurol 1997; 42: 379-382 .

10.

Fischer JS , Rudick RA , Cutter GR , Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force . Mult Scler 1999; 5: 244-250 .

11.

Cutter GR , Baier ML , Rudick RA , Cookfair DL , Fischer JS , Petkau J et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure . Brain 1999; 122: 871-882 .

12.

Miller DH , Albert PS , Barkhof F , Francis G , Frank JA , Hodgkinson S et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force . Ann Neurol 1996; 39: 6-16 .

13.

Miller DH , Grossman RI , Reingold SC , McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis . Brain 1998; 121: 3-24 .